Drug therapy in advanced cardiac life support

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Drug therapy during advanced cardiac life support for cardiac resuscitation continues to evolve, with new experimental and clinical data appearing each year. During the last year, important work has come forth in the following areas: optimal vaso-constrictive agents for improving coronary perfusion pressure during cardiopulmonary resuscitation; antiarrhythmic drug use for refractory ventricular fibrillation during ongoing cardiopulmonary resuscitation; and treatment of postresuscitation myocardial dysfunction. Much of the previous practice of drug therapy during cardiopulmonary resuscitation was based on anecdotal or consensus opinion. Careful prospective evaluation of drug therapy in both experimental and clinical settings is sorely needed. Such data have appeared recently for the use of vasopressin, amiodarone, and dobutamine during and after resuscitation.

Original languageEnglish (US)
Pages (from-to)161-164
Number of pages4
JournalCurrent opinion in critical care
Volume4
Issue number3
DOIs
StatePublished - Jan 1 1998

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Drug therapy in advanced cardiac life support'. Together they form a unique fingerprint.

Cite this